- Email: [email protected]
Freudenberg Filtration takes majority stake in China's Apollo Air-cleaner
NEWS
Valmet seals GL&V acquisition
V
almet has completed the acquisition of North Americabased GL&V, a global provider of technologies and services to the pulp and paper industry, for an enterprise value of approximately E113 million. GL&V supplies technologies, upgrades and optimization services, rebuilds and spare parts for the pulp and paper industry globally. The acquired operations had net sales of approximately E160 million in 2018 and employ about 630 people. GL&V’s washing, oxygen delignification and bleaching operations with Compact Press®, pumps and mixers technology for chemical pulping as well as the related Product Center in Karlstad Sweden are not included in the transaction. GL&V will now be part of Valmet’s Services business line. “The combination of Valmet’s global reach and GL&V’s product and services offering for chemical pulping, stock preparation, papermaking and finishing create a good basis for new business opportunities and for serving our customers even better,” said Pasi Laine, president and CEO of Valmet.
For further information, visit www.valmet.com and www.glv.com
the previous sole proprietor Japan’s Apollo Trading Group (25%), under the name Freudenberg Apollo Filtration Technologies. Freudenberg Filtration Technologies will also bring its current consumer filtration business into the joint venture. For further information, www.freudenberg-filter.com and visit www.apollo-f.com
LiqTech uplists to Nasdaq Capital Market
L
iqTech International Inc has moved the trading of its shares from the NYSE American to the Nasdaq Capital Market. The LiqTech board based its decision on the belief that the Nasdaq Capital Market is better suited for the company’s industry and investors. “Over the last year, we have taken a number of important steps to grow LiqTech into a more established company,” said LiqTech president and CEO Sune Mathiesen. “We appreciate the continued support and confidence of our investors and are excited to be celebrating this move to Nasdaq with them.” Mathiesen and other team members rang the Closing Bell of the Nasdaq Stock Market on 17 April 2019 to celebrate the uplisting. For further information, visit www.liqtech.com
Freudenberg Filtration takes majority stake in China’s Apollo Air-cleaner
F
reudenberg’s Filtration Technologies Business Group has completed its acquisition of a majority shareholding in China’s Apollo Aircleaner Co Ltd (see Filtration Industry Analyst, December 2018). The purchase agreement was signed late last year, and the Chinese antitrust authorities have now approved the acquisition. Apollo Air-cleaner, which provides air and water filtration solutions in China, had 2017 sales of RMB750 million (approximately E96 million) and employs around 1000 people. Apollo will continue as a joint venture between Freudenberg (75%) and 14
Filtration Industry Analyst
Purafil expands R&D lab
G
as phase filtration specialist Purafil has overhauled its lab in Doraville, Georgia to increase functionality and expand testing capabilities. Purafil, which is part of the Filtration Group, has doubled the size of the lab, upgraded its equipment and hired experts in air purification. By expanding services, Purafil can now run more tests to innovate new products faster and offer customers more timely and accurate media analyses. Purafil currently generates over 20 000 analyses per year. The company hopes that the new lab and upgraded its equipment. Purafil says that the lab will earn its ISO 17025-2017 certification this year.
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Subscription Information An annual subscription to Filtration Industry Analyst includes 12 issues and online access for up to 5 users. Subscriptions run for 12 months, from the date payment is received.
More information: www.elsevier.com/journals/institutional/filtrationindustry-analyst/1365-6937 Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) Limited 12976 The content of this newsletter is compiled from a variety of sources including press releases.
For further information, visit www.purafil.com
April 2019
Valmet seals GL&V acquisition
V
almet has completed the acquisition of North Americabased GL&V, a global provider of technologies and services to the pulp and paper industry, for an enterprise value of approximately E113 million. GL&V supplies technologies, upgrades and optimization services, rebuilds and spare parts for the pulp and paper industry globally. The acquired operations had net sales of approximately E160 million in 2018 and employ about 630 people. GL&V’s washing, oxygen delignification and bleaching operations with Compact Press®, pumps and mixers technology for chemical pulping as well as the related Product Center in Karlstad Sweden are not included in the transaction. GL&V will now be part of Valmet’s Services business line. “The combination of Valmet’s global reach and GL&V’s product and services offering for chemical pulping, stock preparation, papermaking and finishing create a good basis for new business opportunities and for serving our customers even better,” said Pasi Laine, president and CEO of Valmet.
For further information, visit www.valmet.com and www.glv.com
the previous sole proprietor Japan’s Apollo Trading Group (25%), under the name Freudenberg Apollo Filtration Technologies. Freudenberg Filtration Technologies will also bring its current consumer filtration business into the joint venture. For further information, www.freudenberg-filter.com and visit www.apollo-f.com
LiqTech uplists to Nasdaq Capital Market
L
iqTech International Inc has moved the trading of its shares from the NYSE American to the Nasdaq Capital Market. The LiqTech board based its decision on the belief that the Nasdaq Capital Market is better suited for the company’s industry and investors. “Over the last year, we have taken a number of important steps to grow LiqTech into a more established company,” said LiqTech president and CEO Sune Mathiesen. “We appreciate the continued support and confidence of our investors and are excited to be celebrating this move to Nasdaq with them.” Mathiesen and other team members rang the Closing Bell of the Nasdaq Stock Market on 17 April 2019 to celebrate the uplisting. For further information, visit www.liqtech.com
Freudenberg Filtration takes majority stake in China’s Apollo Air-cleaner
F
reudenberg’s Filtration Technologies Business Group has completed its acquisition of a majority shareholding in China’s Apollo Aircleaner Co Ltd (see Filtration Industry Analyst, December 2018). The purchase agreement was signed late last year, and the Chinese antitrust authorities have now approved the acquisition. Apollo Air-cleaner, which provides air and water filtration solutions in China, had 2017 sales of RMB750 million (approximately E96 million) and employs around 1000 people. Apollo will continue as a joint venture between Freudenberg (75%) and 14
Filtration Industry Analyst
Purafil expands R&D lab
G
as phase filtration specialist Purafil has overhauled its lab in Doraville, Georgia to increase functionality and expand testing capabilities. Purafil, which is part of the Filtration Group, has doubled the size of the lab, upgraded its equipment and hired experts in air purification. By expanding services, Purafil can now run more tests to innovate new products faster and offer customers more timely and accurate media analyses. Purafil currently generates over 20 000 analyses per year. The company hopes that the new lab and upgraded its equipment. Purafil says that the lab will earn its ISO 17025-2017 certification this year.
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Subscription Information An annual subscription to Filtration Industry Analyst includes 12 issues and online access for up to 5 users. Subscriptions run for 12 months, from the date payment is received.
More information: www.elsevier.com/journals/institutional/filtrationindustry-analyst/1365-6937 Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) Limited 12976 The content of this newsletter is compiled from a variety of sources including press releases.
For further information, visit www.purafil.com
April 2019